FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

126202002: Levothyroxine sodium (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
32188019 Levothyroxine sodium en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
730135010 Levothyroxine sodium (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
820761000172117 lévothyroxine sodique fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Levothyroxine sodium Is a Thyroxine false Inferred relationship Some
Levothyroxine sodium Is a Levothyroxine (substance) false Inferred relationship Some
Levothyroxine sodium This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Thyroid hormone (disposition) true Inferred relationship Some
Levothyroxine sodium This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Levothyroxine (substance) true Inferred relationship Some
Levothyroxine sodium Is a Thyroid hormone true Inferred relationship Some
Levothyroxine sodium Is a Hormone false Inferred relationship Some
Levothyroxine sodium Is a allergène médicamenteux false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing levothyroxine sodium The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Product containing precisely levothyroxine sodium 25 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Levothyroxine sodium 50 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Product containing precisely levothyroxine sodium 100 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Product containing precisely levothyroxine sodium 150 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Levothyroxine sodium 175 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Product containing precisely levothyroxine sodium 200 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Product containing precisely levothyroxine sodium 300 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Levothyroxine sodium 88 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Product containing precisely levothyroxine sodium 112 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Levothyroxine sodium 137 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Levothyroxine sodium 250 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Levothyroxine sodium 0.05mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Levothyroxine sodium 0.075mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Levothyroxine sodium 0.088mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Levothyroxine sodium 0.1mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Levothyroxine sodium 0.112mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Levothyroxine sodium 0.15mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Levothyroxine sodium 0.175mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Levothyroxine sodium 0.125mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Levothyroxine sodium 0.2mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Levothyroxine sodium 0.3mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Levothyroxine sodium o.05mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Levothyroxine sodium 0.15mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Levothyroxine sodium 0.025mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Levothyroxine sodium 200mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Product containing precisely levothyroxine sodium 125 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Product containing precisely levothyroxine sodium 75 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Product containing precisely levothyroxine sodium 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Liotrix preparation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Product containing levothyroxine sodium and liothyronine sodium The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
intoxication accidentelle par la lévothyroxine sodique Causative agent (attribute) False Levothyroxine sodium Inferred relationship Some 1
intoxication intentionnelle par la lévothyroxine sodique Causative agent (attribute) False Levothyroxine sodium Inferred relationship Some 1
intoxication par la lévothyroxine sodique d'intention indéterminée Causative agent (attribute) False Levothyroxine sodium Inferred relationship Some 1
intoxication par la lévothyroxine sodique Causative agent (attribute) False Levothyroxine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 25 microgram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Product containing precisely levothyroxine sodium 50 microgram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Product containing precisely levothyroxine sodium 75 microgram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Product containing precisely levothyroxine sodium 100 microgram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Levothyroxine sodium 125 microgram oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Product containing precisely levothyroxine sodium 150 microgram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Product containing levothyroxine sodium in oral dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some
Product containing precisely levothyroxine sodium 25 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 25 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Levothyroxine sodium Inferred relationship Some 1
Levothyroxine sodium 50 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some 1
Levothyroxine sodium 50 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Levothyroxine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 100 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 100 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Levothyroxine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 150 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 150 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Levothyroxine sodium Inferred relationship Some 1
Levothyroxine sodium 175 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some 1
Levothyroxine sodium 175 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Levothyroxine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 200 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 200 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Levothyroxine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 300 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 300 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Levothyroxine sodium Inferred relationship Some 1
Levothyroxine sodium 88 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some 1
Levothyroxine sodium 88 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Levothyroxine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 112 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 112 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Levothyroxine sodium Inferred relationship Some 1
Levothyroxine sodium 137 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some 1
Levothyroxine sodium 137 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Levothyroxine sodium Inferred relationship Some 1
Levothyroxine sodium 250 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some 1
Levothyroxine sodium 250 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Levothyroxine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 125 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 125 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Levothyroxine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 75 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 75 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Levothyroxine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some 2
Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Levothyroxine sodium Inferred relationship Some 2
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Levothyroxine sodium Inferred relationship Some 1
Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some 2
Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Levothyroxine sodium Inferred relationship Some 2
Product containing precisely levothyroxine sodium 150 microgram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 150 microgram/1 each conventional release oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Levothyroxine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 75 microgram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 75 microgram/1 each conventional release oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Levothyroxine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 50 microgram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 50 microgram/1 each conventional release oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Levothyroxine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 25 microgram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 25 microgram/1 each conventional release oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Levothyroxine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 100 microgram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 100 microgram/1 each conventional release oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Levothyroxine sodium Inferred relationship Some 1
Levothyroxine sodium 125 microgram oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some 1
Levothyroxine sodium 125 microgram oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Levothyroxine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some 2
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Levothyroxine sodium Inferred relationship Some 2
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some 2
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Levothyroxine sodium Inferred relationship Some 2
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some 2
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Levothyroxine sodium Inferred relationship Some 2
Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Levothyroxine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Levothyroxine sodium Inferred relationship Some 2
Product containing precisely levothyroxine sodium 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Levothyroxine sodium Inferred relationship Some 2
Product containing precisely levothyroxine sodium 75 microgram/1 each conventional release oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Levothyroxine sodium Inferred relationship Some 1
Product containing precisely levothyroxine sodium 150 microgram/1 each conventional release oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Levothyroxine sodium Inferred relationship Some 1

Page 1 of 2 End


This concept is not in any reference sets

Back to Start